BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16240294)

  • 1. Quantitative analysis of shape-specific interactions of Rev response element with a positively charged Rev peptide by capillary electrophoresis.
    Han KC; Yu J; Yang EG
    Electrophoresis; 2005 Nov; 26(22):4379-86. PubMed ID: 16240294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
    Wang Y; Hamasaki K; Rando RR
    Biochemistry; 1997 Jan; 36(4):768-79. PubMed ID: 9020774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
    West ML; Ramsdale TE
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of mismatch-binding ligands as inhibitors for Rev-RRE interaction.
    Nakatani K; Horie S; Goto Y; Kobori A; Hagihara S
    Bioorg Med Chem; 2006 Aug; 14(15):5384-8. PubMed ID: 16603366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
    Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
    J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted cleavage of HIV rev response element RNA by metallopeptide complexes.
    Jin Y; Cowan JA
    J Am Chem Soc; 2006 Jan; 128(2):410-1. PubMed ID: 16402818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
    Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
    Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity in the binding of aminoglycosides to HIV-RRE RNA.
    Cho J; Rando RR
    Biochemistry; 1999 Jun; 38(26):8548-54. PubMed ID: 10387102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; CastaƱo ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolvability of the mode of peptide binding by an RNA.
    Iwazaki T; Li X; Harada K
    RNA; 2005 Sep; 11(9):1364-73. PubMed ID: 16043495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of HIV Rev peptides containing peptide nucleic acid that bind HIV RRE IIB RNA.
    Kumagai I; Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem Lett; 2000 Feb; 10(4):377-9. PubMed ID: 10714504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
    Modem S; Reddy TR
    J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for detection of specific nucleic acids by recombinant protein with fluorescent resonance energy transfer.
    Endoh T; Funabashi H; Mie M; Kobatake E
    Anal Chem; 2005 Jul; 77(14):4308-14. PubMed ID: 16013840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heparin-binding peptide from human serum amyloid P component characterized by affinity capillary electrophoresis.
    Heegaard NH
    Electrophoresis; 1998 Mar; 19(3):442-7. PubMed ID: 9551799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.